SCOPUS 정보 검색 플랫폼

Volumn 153, Issue 6, 1995, Pages 1946-1947

Dramatic Prostate Specific Antigen Decrease in Response to Discontinuation of Megestrol Acetate in Advanced Prostate Cancer: Expansion of the Antiandrogen Withdrawal Syndrome

(2) Dawson, Nancy A a McLeod, David G a

a WALTER REED ARMY MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; ANDROGEN RECEPTOR; BICALUTAMIDE; CYPROTERONE ACETATE; ESTRADIOL; ESTROGEN; FLUTAMIDE; KETOCONAZOLE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NILUTAMIDE; PROGESTERONE; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; ORAL DRUG ADMINISTRATION; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY;

AGED; CASE REPORT; HUMAN; MALE; MEGESTROL; MEGESTROL ACETATE; NEOPLASM METASTASIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029007052 PISSN: 00225347 EISSN: None Source Type: Journal
DOI: 10.1016/S0022-5347(01)67365-8 Document Type: Article

Times cited : (103)

References (11)

1
- 0027203411
- Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer
- (1993) J. Clin. Oncol. , vol.11 , pp. 1566
- Scher¹ Kelly²

2
- 0027249588
- Response to flutamide withdrawal in advanced prostate cancer in progression under combination therapy
- (1993) J. Urol. , vol.150 , pp. 908
- Dupont¹ Gomez² Cusan³ Koutsilieris⁴ Labrie⁵

3
- 0028089068
- Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of “hormone-refractory” prostate cancer
- (1994) J. Natl. Cancer Inst. , vol.86 , pp. 222
- Sartor¹ Cooper² Weinberger³ Headlee⁴ Thibault⁵ Tompkins⁶ Steinberg⁷ Figg⁸ Linehan⁹ Myers¹⁰

4
- 0028907804
- Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer
- in press
- (1995) Am J Med
- Figg¹ Sartor² Cooper³ Thibault⁴ Bergan⁵ Dawson⁶ Reed⁷ Myers⁸

5
- 0026591729
- Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation
- (1992) Biochemistry , vol.31 , pp. 2393
- Veldscholte¹ Berrevoets² Brinkmann³ Grootegoed⁴ Mulder⁵

6
- 0024351830
- Aberrant response in in vitro hormone-responsive prostate cancer cells to antiandrogens
- (1989) Prostate , vol.14 , pp. 103
- Wilding¹ Chen² Gelmann³

7
- 0025648521
- Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion
- (1990) J. Steroid Biochem. Molec. Biol. , vol.37 , pp. 849
- Schuurmans¹ Veldscholte² Mulder³

8
- 0028278076
- Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers
- (1994) Cancer Res. , vol.54 , pp. 2861
- Gaddipati¹ McLeod² Heidenberg³ Sesterhenn⁴ Finger⁵ Moul⁶ Srivastava⁷

9
- 85003173512
- Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgen and progesterone
- (1993) Molec. Endocr. , vol.7 , pp. 1541
- Culig¹ Hobisch² Cronauer³ Cato⁴ Hittmair⁵ Radmayr⁶ Eberle⁷ Bartsch⁸ Klocker⁹

10
- 0025257141
- The proliferative effect of “anti-androgens” on the androgen-sensitive human prostate tumor cell line LNCaP
- (1990) Endocrinology , vol.126 , pp. 1457
- Olea¹ Sakabe² Soto³ Sonnenschein⁴

11
- 0028256111
- Prostate-specific antigen decline after Casodex withdrawal: evidence for an antiandrogen withdrawal syndrome
- (1994) Urology , vol.43 , pp. 408
- Small¹ Carroll²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.